Total planned funding: $68,896,729
Clear active filters
U.S. Department of State
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Ethiopia | $12,260,206 |
| Kenya | $11,242,677 |
| Tanzania | $9,670,096 |
| Mozambique | $6,140,485 |
| Uganda | $4,842,209 |
| South Africa | $3,893,916 |
| Nigeria | $3,482,903 |
| Zambia | $2,693,489 |
| Namibia | $2,167,940 |
| Botswana | $2,070,879 |
| Rwanda | $2,009,000 |
| Malawi | $1,931,575 |
| Vietnam | $1,888,043 |
| Lesotho | $1,485,625 |
| Democratic Republic of the Congo | $1,314,181 |
| Eswatini | $639,840 |
| Cambodia | $586,165 |
| Zimbabwe | $260,000 |
| Guyana | $112,500 |
| Côte d'Ivoire | $80,000 |
| Ghana | $80,000 |
| Papua New Guinea | $45,000 |
| Ukraine | $0 |
Organizational Types
| Other USG Agency | $68,836,729 |
| Implementing Agency | $60,000 |
Program Areas
| Management and Operations | $24,765,944 |
| Treatment | $19,062,205 |
| Governance and Systems | $10,495,521 |
| Care | $7,368,449 |
| Prevention | $6,552,409 |
| Testing | $652,201 |
Budget Codes
| HVMS: Management and Operations | $24,765,944 |
| HTXS: Treatment: Adult Treatment | $18,427,543 |
| HLAB: Laboratory Infrastructure | $6,560,130 |
| HKID: Care: Orphans and Vulnerable Children | $3,997,898 |
| OHSS: Health Systems Strengthening | $2,912,516 |
| HMBL: Biomedical Prevention: Blood Safety | $2,283,284 |
| HBHC: Care: Adult Care and Support | $1,745,200 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $1,699,628 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $1,466,494 |
| HVTB: Care: TB/HIV | $1,078,693 |
| HVSI: Strategic Information | $1,022,875 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $956,655 |
| HVCT: Testing: HIV Testing and Counseling | $652,201 |
| PDTX: Treatment: Pediatric Treatment | $605,969 |
| PDCS: Care: Pediatric Care and Support | $546,658 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $73,539 |
| HMIN: Biomedical Prevention: Injection Safety | $72,809 |
| HTXD: Treatment: ARV Drugs | $28,693 |